Accenture and Bengaluru-based HCG Partner for Advance AI-powered Cancer Research, Care

HealthCare Global Enterprises Limited (HCG), one of the largest cancer care networks in India, and Accenture have announced a collaboration to accelerate cancer research and care using advanced AI technologies, including generative AI and deep learning on multi-dimensional and multi-omic patient data. This innovative, data-driven program aims to enhance early detection and treatment for various types of cancer in South Asia.

The collaboration will leverage AI, including generative AI and deep learning, to analyze multi-dimensional and multi-omic patient data.

This strategic partnership combines Accenture’s global expertise and talent in data and AI including AI/ML, generative AI, and quantum computing with deep clinical insights from HCG in oncology to enable early detection and treatment for various types of cancer.

Accenture will use advanced technologies such as image analysis software, informatics, and novel algorithms to study molecular alterations and develop new drug targets.

The initiative aims to advance the quality of therapy and care by enabling new treatment algorithms for precision medicine.

The collaboration will showcase data-driven clinical practice and enhance the overall efficiency of patient care. This partnership is expected to play a pivotal role in cancer research and care, addressing the needs of patients and benefiting the global healthcare industry.

Dr. B. S. Ajaikumar, Executive Chairman of HCG, emphasized the importance of tech-driven advancements in research and academics for optimizing cancer care.

Headquartered in Bengaluru, HCG has also worked with Microsoft to implement cloud-based solutions and AI technologies for better data management and analysis in oncology. In April 2022, HCG launched Extended Reality Lab using the Microsoft HoloLens 2 at the HCG Cancer Hospital Bengaluru.

HCG operates multiple entities, including tertiary care hospitals, cancer care centers, and diagnostic centers.

Senthil Ramani, global lead of Data and AI at Accenture, said, “Next-gen computing, including generative AI, combined with deep biological and clinical expertise, can play a pivotal role in cancer research and care, addressing needs of patients and benefiting the global healthcare industry at large. Together with HCG, we are blending our global expertise in data and AI along with life sciences R&D to rapidly and accurately improve decision-making for the treatment and care for cancer patients in South Asia, and across the world.”
Advertisements

Post a Comment

Comment

أحدث أقدم